WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today announced that the Com…
Uncategorized
Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious med…
Uncategorized
VIDEO: Extension studies shed light on wet AMD treatments
ORLANDO — In this video from the American Academy of Ophthalmology meeting, Esther M. Bowie, MD, discusses results from the AVONELLE-X trial, the PULSAR trial and the Portal study in wet age-related macular degeneration.In AVONELLE-X, patients with wet…
Dangerous Catch: A Look at Eye Trauma From Fishing Incidents
Eye injuries linked to fishing have declined over the last 20 years, with contusions or corneal abrasions being the most common diagnoses and fishhooks and rods being the most common causes. Medscape Medical News
Uncategorized
How EDs became too busy to see the subtle signs of illness
Every emergency medicine physician has a case that lingers long after the shift ends — the patient who appeared stable, said they felt “a little better,” but ultimately wasn’t OK.We carry those cases with us long after the shift ends. Usually, the remi…
Two Global Leaders in Eyesight Restoration, Advancing Sight Network and Miracles In Sight, Announce Merger
BIRMINGHAM, Ala. & CLEMMONS, N.C.–(BUSINESS WIRE)–Advancing Sight Network and Miracles In Sight today jointly announced the merger of the two organizations, which will begin operating as one on January 1, 2026. Globally, at least 253 million people l…